首頁 > 市場調查報告書 > 製藥

感染疾病

市場調查報告書

商品編碼

2150672

真菌感染疾病診斷市場報告：趨勢、預測和競爭分析（至2035年）

Fungal Infection Diagnosis Market Report: Trends, Forecast and Competitive Analysis to 2035

出版日期: 2026年10月15日 | 出版商:

Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄圖表

黴菌感染疾病診斷市場

受醫院、診斷中心和研究機構的機會推動，全球真菌感染疾病診斷市場前景廣闊。預計到2035年，全球真菌感染疾病診斷市場規模將達到198億美元，高於2027年的113億美元，2027年至2035年的複合年成長率（CAGR）為9.5%。推動該市場成長的關鍵因素包括真菌感染疾病盛行率的上升、對早期診斷解決方案日益成長的需求以及診斷技術的進步。

根據 Lucintel 的預測，按產品類型分類，「儀器」類別預計將在預測期內呈現最高的成長率，這主要得益於真菌診斷自動化設備的成長。
按最終用途分類，「醫院」領域預計將在預測期內呈現最高的成長率，這是由於醫院感染引起的侵襲性真菌感染疾病的發生率不斷上升所致。
從區域來看，由於北美地區對真菌感染疾病的認知較高，且擁有完善的專業診斷基礎設施，預計北美地區在整個預測期內將呈現最高的成長率。

真菌感染疾病診斷市場的新趨勢

預計2025年至2027年間，真菌感染疾病診斷市場將從培養為基礎的方法轉向快速檢測、多重檢測和定序方法。 Lucintel預測，隨著真菌感染疾病率的上升和抗真菌藥物抗藥性的增強，快速檢測的重要性將日益凸顯，這將有助於臨床醫生做出更明智的決策。此外，Lucintel也預計，對跨學科診斷系統的投資將會增加。

快速分子檢測：自 2025 年起，FDA 已批准多種 PCR 檢測板用於輔助檢測念珠菌。這些改進將獲得檢測結果的時間從數天縮短至數小時。在加護病房(ICU)，對改善治療效果和減少不必要的抗生素使用的重視，進一步增加了對快速診斷方法的需求。
基於症候群的檢測：預計到2026年，基於血液和呼吸道培養的診斷檢測將擴展到包括真菌病原體。其中一些新一代平台將具備多重檢測功能，能夠檢測和區分20多種不同的病原體。
公共衛生：2023 年，美國報告了 6000 多例確診的耳念珠菌感染病例，其他唑類抗藥性念珠菌的病例也在增加，因此，對抗藥性的關注可能會進一步增加，以指南公共衛生和臨床決策。
分散式診斷：2025年至2027年間，財政困難國家的醫院將開始採用側向流動抗原檢測法診斷隱球菌病和其他性行為感染。這些檢測將與小型攜帶式分析儀配合使用。因此，醫院將能夠減少對中心檢查室進行這些檢測的依賴。進行這些檢測所需的基礎設施也將減少。檢測將在大都會圈以外的地區普及。
數位化和人工智慧驅動的診斷：基於人工智慧和其他自動化技術的軟體和應用程式將分析各種診斷影像。人工智慧還將分析專業測試的結果，並有助於結果的標準化。雖然診斷測試的自動化以及用於分析診斷結果的類似應用程式將持續成長，但對專業人員的招募和培訓需求仍然存在。產業面臨的挑戰將是這些系統的大規模部署。

預計能夠實現更快速診斷的產品將帶來最強勁的市場成長。高附加價值領域將主要由分子生物學為基礎的平台佔據。然而，在資源匱乏的環境中，抗原檢測預計仍將佔據主導地位。監測病原體威脅的壓力將加速公共衛生和臨床診斷之間的合作。易用性、可靠性以及與醫療財務系統的整合將是企業在該領域取得成功的關鍵。

真菌感染疾病診斷市場近期趨勢

鑑於快速識別侵襲性真菌感染疾病的重要性，預計未來幾年市場將快速成長。自動化檢測、分子檢測和多重檢測將在2025年至2027年間特別突出。據Lucintel公司稱，這些檢測方法的普及程度預計將取決於臨床證據的累積和保險報銷政策的製定。

監管政策：2025年2月，FDA批准了曲霉菌檢測，增加了對其他真菌檢測的需求。 FDA和其他監管機構對真菌檢測的批准，很可能會促使這些檢測方法從專業檢查室推廣到其他機構。
多重檢測：同樣在2025年，生物梅里埃宣布開發出多重檢測卡，能夠檢測20多種不同的病原體。這進一步鞏固了該公司致力於開發針對多種病原體的症候群檢測方法的承諾。
檢測自動化：BD公司宣布計劃在2025年實現檢查室大部分檢體檢測的自動化。未來五年，對多種真菌病原體檢測自動化的需求預計將會成長。
策略合作：2025年10月，一家大型參考檢查室網路與一家分子診斷公司達成合作，將其專有的檢查室檢測服務擴展至100個客戶地點。預計類似的合作最終將使真菌檢測符合保險報銷條件。
數位診斷：2026年3月，一家診斷軟體領域的人工智慧（AI）公司公佈了其在解讀超過1萬張臨床影像方面的效能評估結果。該平台及類似平台無疑將推動真菌學的發展。如果此類數位決策支援能夠幫助解讀臨床影像，檢查室將不再需要真菌學專科醫生。

未來五年，診斷檢查室將逐步過渡到整合分子診斷、自動化和數位成像技術的整合系統。降低成本和提升檢測價值將成為重點。免疫力缺乏功能低下患者數量的不斷成長帶來的日益沉重的負擔，也將推動診斷檢測領域的類似變革。現有的檢查室自動化和整合系統將有助於這些檢測方法的推廣應用。提升價值和降低成本仍將是關注的重點。

歐洲真菌感染疾病診斷市場：按產品類型分類
歐洲真菌感染疾病診斷市場：依最終用途分類
德國真菌感染疾病診斷市場
法國真菌感染疾病診斷市場
義大利真菌感染疾病診斷市場
西班牙真菌感染疾病診斷市場
英國真菌感染疾病診斷市場

第11章：亞太地區真菌感染疾病診斷市場

亞太地區真菌感染疾病診斷市場：依產品類型分類
亞太地區真菌感染疾病診斷市場：依最終用途分類
中國真菌感染疾病診斷市場
印度真菌感染疾病診斷市場
日本真菌感染疾病診斷市場
韓國真菌感染疾病診斷市場
印尼真菌感染疾病診斷市場

第12章：真菌感染疾病診斷的全球市場

其他區域真菌感染疾病診斷市場：依產品類型分類
其他區域真菌感染疾病診斷市場：依最終用途分類
中東真菌感染疾病診斷市場
南美洲真菌感染疾病診斷市場
非洲真菌感染疾病診斷市場

第13章競爭分析

產品系列分析
業務整合
波特五力分析
市佔率分析

第14章機會與策略分析

價值鏈分析
成長機會分析
新趨勢：全球真菌感染疾病診斷市場
戰略分析

第15章：價值鏈關鍵企業的企業概況

競爭分析概述
Pfizer Inc.
Merck & Co., Inc.
Roche Diagnostics
Abbott Laboratories
Siemens Healthineers
Thermo Fisher Scientific Inc.
bioMerieux SA
Beckman Coulter, Inc.
Bio-Rad Laboratories, Inc.
Becton, Dickinson and Company

第16章附錄

簡介目錄圖表

Fungal Infection Diagnosis Market

The future of the global fungal infection diagnosis market looks promising with opportunities in the hospital, diagnostic center, and research laboratory markets. The global fungal infection diagnosis market is expected to reach an estimated $19.8 billion by 2035 from $11.3 billion in 2027 with a CAGR of 9.5% from 2027 to 2035. The major drivers for this market are the increasing prevalence of fungal infections, the rising demand for early diagnosis solutions, and the growing advancements in diagnostic technologies.

Lucintel forecasts that, within the product type category, instruments is expected to witness the highest growth over the forecast period due to increase in automated instruments for fungal diagnosis.
Within the end use category, hospitals is expected to witness the highest growth over the forecast period due to increasing rates of hospital-associated invasive fungal infections.
In terms of regions, North America is expected to witness the highest growth over the forecast period due to high levels of awareness and specialized diagnostic infrastructure for fungal infections.

Emerging Trends in Fungal Infection Diagnosis Market

The fungal infection diagnosis market will move from culture-based methods to rapid, multiplexed and sequencing methods from 2025 to 2027. Lucintel predicts that with rising rates of fungal infection and resistance to antifungal drugs, there will be an emphasis on rapid testing to help clinicians make informed decisions. Additionally, Lucintel projects that funding will be directed towards interdisciplinary diagnostic systems.

Rapid Molecular Testing: Beginning in 2025, the FDA gave clearance to multiple PCR panels to help in the detection of Candida. With these improvements, the time to result became hours instead of days. Intensive care units (ICUs) are focused on improving outcomes and eliminating unnecessary antimicrobial use, further increasing the demand for rapid diagnostics.
Syndromic Testing: In 2026, blood and respiratory culture-based diagnostics will be expanded to include fungal pathogens. Some of these next-generation platforms will be multiplexed to detect and distinguish over 20 pathogens.
Public Health: With over 6,000 confirmed cases of Candida auris reported in the U.S. in 2023, and other azole-resistant Candida species on the rise, a greater emphasis will be placed on resistance to help guide public health and clinical decision making.
Decentralized Diagnosis: In the 2025-2027 time frame, hospitals in more financially restricted countries will begin to use lateral flow antigen tests for cryptococcosis and other invasive infections. These tests will be used in conjunction with compact size, portable analysers. As a result, hospitals will be less dependent on centralized laboratories to perform these tests. Also, less infrastructure will be required to perform these tests. The tests will be performed outside of large, metropolitan areas.
Digital and Artificial Intelligence (AI) Based Diagnostics: Software and other applications based on artificial intelligence and other automation will interpret various diagnostic images. AI will also interpret results from specialized tests and help standardize results. Although similar applications for automation of diagnostic tests and interpretation of diagnostic results will continue to increase, there will still be a need to employ and train specialized personnel. The challenge for the industry will be implementing these systems on a large scale.

We expect strongest market growth for products that allow more rapid diagnosis. Premiums will be primarily captured by molecular biology-based platforms. However, in resource-constrained settings, the main reliance will continue to be on antigen-based tests. The pressure to perform surveillance of pathogenic threats will foster collaboration of public health and clinical diagnostics. Simplicity of use, reliability, and integration with the health care financial system will help companies thrive in this space.

Recent Developments in the Fungal Infection Diagnosis Market

The market is expected to grow rapidly in the next few years due to the importance of swiftly identifying invasive fungal infections. From 2025 to 2027, particular interest will be in automated, molecular, and multiplexed tests. According to Lucintel, the availability of such tests will depend on the development of the body of clinical evidence and reimbursement policies.

Regulatory Policy: In February 2025, the FDA cleared a test for Aspergillus, and demand for other fungal tests also increased. The FDA's and other regulatory agencies' acceptance of fungal tests will move the adoption of such tests from specialized labs to other locations.
Multiplex Tests: Also in 2025, bioMerieux announced the development of a multiplex card that would test for 20 or more pathogens. This further solidified the company's commitment to develop a syndromic test for multiple pathogens.
Laboratory Test Automation: In 2025, BD also committed to automate a significant portion of laboratory sample testing. High demand for automation of testing for multiple fungal pathogens is expected in the next 5 years.
Strategic Partnerships: One of the largest reference laboratory networks partnered with a molecular diagnostics company in October 2025 to extend laboratory-developed testing to 100 customer locations. With similar partnerships, fungal assays will ultimately be positioned to gain reimbursement.
Digital Diagnostics: An artificial intelligence (AI) company in diagnostic software reported in March 2026 that it evaluated its performance in interpreting 10,000-plus clinical images. The platform, along others like it, will surely facilitate mycology. With such digital decision support, interpretation of clinical images will allow laboratories to skirt the need for mycology subspecialists.

In the next five years, diagnostic laboratories will move toward more integrated systems that incorporate molecular diagnostics, automation, and digital interpretation. There will be a particular emphasis on cost reduction and increased value, e.g., of testing. Expanding burdens of immunocompromised patient populations will motivate similar changes in diagnostic testing. Existing lab automation and integrated systems will ease adoption of such testing. The focus will remain on value and reduction of costs.

Strategic Growth Opportunities in the Fungal Infection Diagnosis Market

The increased incidence of fungal infections and associated resistant pathogens has created opportunities in the fungal infection diagnosis market. Several factors including the existence of an immunocompromised patient population, increased incidence of hospital-acquired infections, and other healthcare associated infections will offer opportunities beyond 2024. Rapid molecular diagnostic tests, if made available, will further expand the market. Lucintel has identified innovative assay development and extension of the distribution channel of diagnostics as the largest areas of opportunities for market participants.

Point of Carer Molecular Testing: There are several opportunities in molecular diagnostics to perform rapid point-of-care testing to identify pathogens. The U.S. Food and Drug Administration (FDA) granted 20 marketing authorizations to manufacturers of molecular infectious disease diagnostic tests by May 2025. With rapid molecular diagnostic tests, healthcare providers will be able to avoid making empiric treatment decisions and improve infection control practices.
Antifungal Resistance Testing: Fungal pathogens are also becoming multidrug-resistant. As treatment failures occur more frequently, clinical laboratories will be required to perform tests to identify fungal pathogens as well as determine fungal pathogens' antimicrobial susceptibility.
Respiratory Fungal Diagnostics: In-vitro diagnostic testing for respiratory cancers, aspergillosis, and other respiratory infections is desperately needed for patients in oncology, transplant, and critical care. In March 2025, the WHO's fungal-priority framework listed 19 fungal pathogens of public health concern. The expansion of rapid, point-of-care diagnostic testing will greatly enhance traditional microbiological culture.
Veterinary and Agricultural Markets: Timely differentiation of fungal versus bacterial infections is critical for the animal health industry as well as livestock and poultry production. In January 2025, the World Health Organization (WHO) reported six member states of the Food and Agriculture Organization (FAO) initiated national surveillance of AMR in animals. There is ample opportunity for new market development of rapid veterinary testing.
Integration of Fungal Testing Into Clinical Laboratories: There is increasing adoption of connected, integrated diagnostic instruments and consumables. In June 2025, several major diagnostics companies reported double-digit growth for their software and services offerings. The integration of software and services will accelerate adoption of fungal testing.

The success of new, innovative diagnostic tests will be largely influenced by reimbursement policies. The unmet need for rapid diagnostic tests to aid in the management of patients with suspected invasive fungal infections in underserved regions of the world is abundantly clear.

Fungal Infection Diagnosis Market Drivers and Challenges

Factors fostering the fungal infection diagnosis market include increasing incidents of fungal infections, accelerating molecular technology, and advances in regulations. One of the key areas for market growth is low and middle income countries. Lucintel's report identifies acceptance of technology and access to diagnostics as key factors. Other factors including costs, skills, and regulations may limit market growth. In the forecast period, market growth will be achieved by manufactures who are able integrate advanced technologies in diagnostics in their products.

The factors responsible for driving this market include:

Customer Requests: More cases of immunocompromised patients (such as cancer patients and transplant patients) increase the need for testing to diagnose fungal infections. In 2025, the World Health Organization (WHO) indicated that fungal pathogens caused more than 6 million cases of infection and appeal crimes. Funeral burdens increase the need for fungal infection testing. Fungal pathogens are often misdiagnosed, and, as a result, fungal infections are often treated with antibiotics. The goal is to expedite diagnosis to lower mortality rates.
Innovations in Technology: Diagnostic technologies (such as polymerase chain reaction and next-generation sequencing) and artificial intelligence (AI) continue to improve. Simultaneously, traditional methods (such as culture) also improve. Since the beginning of 2025, several diagnostics laboratories integrated next-generation sequencing to shorten the time to result and increase the breadth of pathogens detected. In the next three to five years, further integration of diagnostics and the use of advanced platforms will decrease the need for transport of patient samples to central laboratories and reduce the need for repeat testing.
Regulatory Support: An increased demand for rapid diagnostics for Neglected Infectious Diseases (NIDs) is reflected in regulations for Antimicrobial Resistance (AMR) and other initiatives. More accessible guidelines and pathways for assessment and review promoted greater transparency in the regulatory process and allowed for better prioritization of diagnostics development. Regulatory frameworks based on risk, performance, and quality, rather than on adherence to traditional standards and processes, were strengthened in 2025 in Europe and the U.S., and will continue to ease the development of unmet hospital needs diagnostics. Greater regulatory clarity helped reduce assessed risk and improved confidence in the diagnostics market. A greater focus on AMR promoted partnering to address novel diagnostic needs, including diagnostics for emerging and "hot zone" fungal pathogens.
Sustainability: The growing focus on lab processes in "Laboratory Stewardship" and sustainability initiatives has substantially reduced disposable plastic consumption and energy usage in laboratory testing, while improving turnaround time and reducing the number of procedures performed on a given patient. Novel testing methods and enhanced workflow improved resource utilization in laboratory testing. In the next three to five years, sustainability will be a substantial consideration by large health systems when procuring laboratory services, and will provide an edge to medical device companies that integrate sustainable design into their products.
Manufacturing Efficiency: Standardized components and improved automation and scalability of cartridge manufacturing have reduced the variation in supplier's ability to manufacture fungal diagnosis products. Additionally, improvements in automation of laboratory systems enabled integration of multiple specimen types and reduced manual steps. Improvements in laboratory systems and automation increased the throughput and standardized processes. In 2025, the impacts of such improvements were visible in the health care systems. The improvements enhanced reliability of fungal diagnostic product supply. Improvements in manufacturing fungal diagnosis products coupled with reduction in per-test costs fostered market growth and favorable supply during outbreaks. The trends will continue in the next 3 to 5 years and improve access to advanced fungal diagnosis products.

The challenges facing this market include:

Complex Disease Biology: Fungal infections share signs and symptoms with viral and bacterial infections. This results in underreporting of fungal infections. Furthermore, fungal infections may occur in combination with other infections. The low fungal load in specimen may go undetected. As a result, culture and other traditional fungal diagnostic tests may yield inconclusive or inaccurate results. In 2025, tests to detect various fungal infections relied on a combination of assays. The challenges described above coupled with rapid variability of fungal infections will continue to pose challenges to diagnostic manufacturers in the next 3 to 5 years.
Reimbursement and Cost Constraints: Many hospitals in developing countries are constrained by the need to rely on older forms of microbiology and invasive culture-based methods. This is in part due to the lack of test reimbursement. Innovations in molecular tests can reduce costs, increase speed, and improve the overall quality of diagnostic testing. However, various economic and coverage barriers constrain the adoption of innovative diagnostic tests. During the next 3-5 years, it is expected that diagnostic test manufacturers will develop lower cost tests and create tests to meet the needs of higher resource settings and lower resource settings.
Gaps in Infrastructure and Skills: The ability of a laboratory to diagnose fungal infections is dependent on several factors including the availability of equipment, electricity, and trained personnel. Inequalities in access to molecular testing and other subspecialties exist between large urban hospitals and small rural hospitals. Complex and sophisticated diagnostic testing systems may not be appropriate for lower resource settings. Even in the next several years, demand for basic, automated, and easy-to-use diagnostic testing systems will exist. Healthcare systems and manufacturers will have to implement changing strategies including the improvement of transportation, storage and quality assurance of lab tests.

Driven by emerging threats of infectious diseases and the need for swift and accurate clinical judgment by the healthcare professionals, the fungal infection diagnosis market is expected to grow in the coming years. The identification of molecules involved in pathogenesis and incorporation of automation in diagnostic tests will facilitate the growth of this market. Additionally, focus on reduction of the environmental impact and improved efficiencies in biomanufacturing will facilitate the adoption of fungal infection diagnosis tests. Despite the favorable trends for the fungal infection diagnosis market, there exist barriers on account of intricacies in pathogenesis of various infectious diseases, variations in healthcare systems, and insufficient healthcare infrastructure. First movers in this space will have to simplify their product offerings to adapt to the varying needs of customers. Improved diagnostic and treatment services will have to be offered to improve outcome equity for patients.

List of Fungal Infection Diagnosis Market Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies fungal infection diagnosis market companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the fungal infection diagnosis market companies profiled in this report include-

Pfizer Inc.
Merck & Co., Inc.
Roche Diagnostics
Abbott Laboratories
Siemens Healthineers
Thermo Fisher Scientific Inc.
bioMerieux SA
Beckman Coulter, Inc.
Bio-Rad Laboratories, Inc.
Becton, Dickinson and Company

Fungal Infection Diagnosis Market by Segment

The study includes a forecast for the global fungal infection diagnosis market by product type, test type, application, end use, and region.

Fungal Infection Diagnosis Market by Product Type [Value ($B) from 2019 to 2035]:

Instruments
Reagents & Kits
Software

Fungal Infection Diagnosis Market by Test Type [Value ($B) from 2019 to 2035]:

Molecular Tests
Immunoassays
Microscopy
Culture-Based Tests
Others

Fungal Infection Diagnosis Market by Application [Value ($B) from 2019 to 2035]:

Hospitals
Clinics
Diagnostic Laboratories
Research Institutes
Others

Fungal Infection Diagnosis Market by End Use [Value ($B) from 2019 to 2035]:

Hospitals
Diagnostic Centers
Research Laboratories
Others

Fungal Infection Diagnosis Market by Region [Value ($B) from 2019 to 2035]:

North America
Europe
Asia Pacific
The Rest of the World

Country Wise Outlook for the Fungal Infection Diagnosis Market

The fungal diagnosis industry is experiencing changes due to enhanced surveillance, FDA regulations and advancements in molecular testing. The emphasis between 2025-2027 is on development of rapid testing methods to detect invasive fungal infections and determine levels of antifungal resistance. The surveillance and testing industry remains attractive to investors.

United States: Recently, a number of CMS and CDC funded laboratories have been established. Companies have developed multiplex assays to detect and characterize fungal pathogens. In 2025, the CDC announced it was in the process of establishing fungal disease programs in over 30 states. It is expected that in the next 3-5 years, thanks to recent initiatives, many hospitals will be equipped with rapid tests to detect fungal infections.
China: New initiatives to improve fungal testing and other advanced microbiology and molecular testing are being implemented in hospitals. Infectious disease surveillance also continues. It is expected that in the next few years, many hospitals will be equipped with advanced testing and diagnostic devices.
Germany: Germany is progressing towards aligning it's in vitro diagnostic (IVD) framework with the EU's. During this time, it is investing in quality control and antimicrobial resistance (AMR) monitoring. In May 2025, the European Commission confirmed that the Framework for Legislation for certain High-risk IVDs allowed continued marketing of these IVDs. As such, high-risk IVDs for fungal assays will remain available until 2027. German Laboratories and Manufacturers can use this time to complete the validation of compliant fungal assays.
India: Increased investments in public and private sector laboratories, and diagnostics, has improved access to laboratory testing in India. In February 2025, the Indian Union budget allocated more than 99,858 crore rupees to the Health and Family Welfare sector. These increased investments can help fund diagnostic infrastructure and improve diagnosis of fungal infections across India.
Japan: Changes in regulations to improve the quality of IVDs and the adoption of advanced diagnostic automation is expected to improve hospital diagnostics in the country in the coming years. In April 2025, the Ministry of Health, Labour and Welfare announced renewal of contracts for 1000+ IVDs. Positive reimbursement policy will help hospitals adopt advanced automated diagnostic systems.

Features of the Global Fungal Infection Diagnosis Market

Market Size Estimates: fungal infection diagnosis market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2019 to 2026) and forecast (2027 to 2035) by various segments and regions.
Segmentation Analysis: fungal infection diagnosis market size by various segments, such as by product type, test type, application, end use, and region in terms of value ($B).
Regional Analysis: fungal infection diagnosis market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different product types, test types, applications, end uses, and regions for the fungal infection diagnosis market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the fungal infection diagnosis market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the fungal infection diagnosis market by product type (instruments, reagents & kits, and software), test type (molecular tests, immunoassays, microscopy, culture-based tests, and others), application (hospitals, clinics, diagnostic laboratories, research institutes, and others), end use (hospitals, diagnostic centers, research laboratories, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 8 years and what has its impact been on the industry?

1. Executive Summary

2. Market Overview

2.1 Background and Classifications
2.2 Supply Chain

3. Market Trends & Forecast Analysis

3.1 Macroeconomic Trends and Forecasts
3.2 Industry Drivers and Challenges
3.3 PESTLE Analysis
3.4 Patent Analysis
3.5 Regulatory Environment

4. Global Fungal Infection Diagnosis Market by Product Type

4.1 Overview
4.2 Attractiveness Analysis by Product Type
4.3 Instruments : Trends and Forecast 2019 to 2035
4.4 Reagents & Kits : Trends and Forecast 2019 to 2035
4.5 Software : Trends and Forecast 2019 to 2035

5. Global Fungal Infection Diagnosis Market by Test Type

5.1 Overview
5.2 Attractiveness Analysis by Test Type
5.3 Molecular Tests : Trends and Forecast 2019 to 2035
5.4 Immunoassays : Trends and Forecast 2019 to 2035
5.5 Microscopy : Trends and Forecast 2019 to 2035
5.6 Culture-Based Tests : Trends and Forecast 2019 to 2035
5.7 Others : Trends and Forecast 2019 to 2035

6. Global Fungal Infection Diagnosis Market by Application

6.1 Overview
6.2 Attractiveness Analysis by Application
6.3 Hospitals : Trends and Forecast 2019 to 2035
6.4 Clinics : Trends and Forecast 2019 to 2035
6.5 Diagnostic Laboratories : Trends and Forecast 2019 to 2035
6.6 Research Institutes : Trends and Forecast 2019 to 2035
6.7 Others : Trends and Forecast 2019 to 2035

7. Global Fungal Infection Diagnosis Market by End Use

7.1 Overview
7.2 Attractiveness Analysis by End Use
7.3 Hospitals : Trends and Forecast 2019 to 2035
7.4 Diagnostic Centers : Trends and Forecast 2019 to 2035
7.5 Research Laboratories : Trends and Forecast 2019 to 2035
7.6 Others : Trends and Forecast 2019 to 2035

8. Regional Analysis

8.1 Overview
8.2 Global Fungal Infection Diagnosis Market by Region

9. North American Fungal Infection Diagnosis Market

9.1 Overview
9.2 North American Fungal Infection Diagnosis Market by Product Type
9.3 North American Fungal Infection Diagnosis Market by End Use
9.4 The United States Fungal Infection Diagnosis Market
9.5 Canadian Fungal Infection Diagnosis Market
9.6 Mexican Fungal Infection Diagnosis Market

10. European Fungal Infection Diagnosis Market

10.1 Overview
10.2 European Fungal Infection Diagnosis Market by Product Type
10.3 European Fungal Infection Diagnosis Market by End Use
10.4 German Fungal Infection Diagnosis Market
10.5 French Fungal Infection Diagnosis Market
10.6 Italian Fungal Infection Diagnosis Market
10.7 Spanish Fungal Infection Diagnosis Market
10.8 The United Kingdom Fungal Infection Diagnosis Market

11. APAC Fungal Infection Diagnosis Market

11.1 Overview
11.2 APAC Fungal Infection Diagnosis Market by Product Type
11.3 APAC Fungal Infection Diagnosis Market by End Use
11.4 Chinese Fungal Infection Diagnosis Market
11.5 Indian Fungal Infection Diagnosis Market
11.6 Japanese Fungal Infection Diagnosis Market
11.7 South Korean Fungal Infection Diagnosis Market
11.8 Indonesian Fungal Infection Diagnosis Market

12. ROW Fungal Infection Diagnosis Market

12.1 Overview
12.2 ROW Fungal Infection Diagnosis Market by Product Type
12.3 ROW Fungal Infection Diagnosis Market by End Use
12.4 Middle Eastern Fungal Infection Diagnosis Market
12.5 South American Fungal Infection Diagnosis Market
12.6 African Fungal Infection Diagnosis Market

13. Competitor Analysis

13.1 Product Portfolio Analysis
13.2 Operational Integration
13.3 Porter's Five Forces Analysis
- Competitive Rivalry
- Bargaining Power of Buyers
- Bargaining Power of Suppliers
- Threat of Substitutes
- Threat of New Entrants
13.4 Market Share Analysis

14. Opportunities & Strategic Analysis

14.1 Value Chain Analysis
14.2 Growth Opportunity Analysis
- 14.2.1 Growth Opportunity by Product Type
- 14.2.2 Growth Opportunity by Test Type
- 14.2.3 Growth Opportunity by Application
- 14.2.4 Growth Opportunity by End Use
14.3 Emerging Trends in the Global Fungal Infection Diagnosis Market
14.4 Strategic Analysis
- 14.4.1 New Product Development
- 14.4.2 Certification and Licensing
- 14.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

15. Company Profiles of the Leading Players Across the Value Chain

15.1 Competitive Analysis Overview
15.2 Pfizer Inc.
- Company Overview
- Fungal Infection Diagnosis Market Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
15.3 Merck & Co., Inc.
- Company Overview
- Fungal Infection Diagnosis Market Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
15.4 Roche Diagnostics
- Company Overview
- Fungal Infection Diagnosis Market Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
15.5 Abbott Laboratories
- Company Overview
- Fungal Infection Diagnosis Market Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
15.6 Siemens Healthineers
- Company Overview
- Fungal Infection Diagnosis Market Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
15.7 Thermo Fisher Scientific Inc.
- Company Overview
- Fungal Infection Diagnosis Market Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
15.8 bioMerieux SA
- Company Overview
- Fungal Infection Diagnosis Market Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
15.9 Beckman Coulter, Inc.
- Company Overview
- Fungal Infection Diagnosis Market Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
15.10 Bio-Rad Laboratories, Inc.
- Company Overview
- Fungal Infection Diagnosis Market Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
15.11 Becton, Dickinson and Company
- Company Overview
- Fungal Infection Diagnosis Market Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing

16. Appendix

16.1 List of Figures
16.2 List of Tables
16.3 Research Methodology
16.4 Disclaimer
16.5 Copyright
16.6 Abbreviations and Technical Units
16.7 About Us
16.8 Contact Us

簡介目錄圖表

List of Figures

Figure 1.1: Trends and Forecast for the Global Fungal Infection Diagnosis Market
Figure 2.1: Usage of Fungal Infection Diagnosis Market
Figure 2.2: Classification of the Global Fungal Infection Diagnosis Market
Figure 2.3: Supply Chain of the Global Fungal Infection Diagnosis Market
Figure 3.1: Trends of the Global GDP Growth Rate
Figure 3.2: Trends of the Global Population Growth Rate
Figure 3.3: Trends of the Global Inflation Rate
Figure 3.4: Trends of the Global Unemployment Rate
Figure 3.5: Trends of the Regional GDP Growth Rate
Figure 3.6: Trends of the Regional Population Growth Rate
Figure 3.7: Trends of the Regional Inflation Rate
Figure 3.8: Trends of the Regional Unemployment Rate
Figure 3.9: Trends of Regional Per Capita Income
Figure 3.10: Forecast for the Global GDP Growth Rate
Figure 3.11: Forecast for the Global Population Growth Rate
Figure 3.12: Forecast for the Global Inflation Rate
Figure 3.13: Forecast for the Global Unemployment Rate
Figure 3.14: Forecast for the Regional GDP Growth Rate
Figure 3.15: Forecast for the Regional Population Growth Rate
Figure 3.16: Forecast for the Regional Inflation Rate
Figure 3.17: Forecast for the Regional Unemployment Rate
Figure 3.18: Forecast for Regional Per Capita Income
Figure 3.19: Driver and Challenges of the Fungal Infection Diagnosis Market
Figure 4.1: Global Fungal Infection Diagnosis Market by Product Type in 2019, 2026, and 2035
Figure 4.2: Trends of the Global Fungal Infection Diagnosis Market ($B) by Product Type
Figure 4.3: Forecast for the Global Fungal Infection Diagnosis Market ($B) by Product Type
Figure 4.4: Trends and Forecast for Instruments in the Global Fungal Infection Diagnosis Market (2019-2035)
Figure 4.5: Trends and Forecast for Reagents & Kits in the Global Fungal Infection Diagnosis Market (2019-2035)
Figure 4.6: Trends and Forecast for Software in the Global Fungal Infection Diagnosis Market (2019-2035)
Figure 5.1: Global Fungal Infection Diagnosis Market by Test Type in 2019, 2026, and 2035
Figure 5.2: Trends of the Global Fungal Infection Diagnosis Market ($B) by Test Type
Figure 5.3: Forecast for the Global Fungal Infection Diagnosis Market ($B) by Test Type
Figure 5.4: Trends and Forecast for Molecular Tests in the Global Fungal Infection Diagnosis Market (2019-2035)
Figure 5.5: Trends and Forecast for Immunoassays in the Global Fungal Infection Diagnosis Market (2019-2035)
Figure 5.6: Trends and Forecast for Microscopy in the Global Fungal Infection Diagnosis Market (2019-2035)
Figure 5.7: Trends and Forecast for Culture-Based Tests in the Global Fungal Infection Diagnosis Market (2019-2035)
Figure 5.8: Trends and Forecast for Others in the Global Fungal Infection Diagnosis Market (2019-2035)
Figure 6.1: Global Fungal Infection Diagnosis Market by Application in 2019, 2026, and 2035
Figure 6.2: Trends of the Global Fungal Infection Diagnosis Market ($B) by Application
Figure 6.3: Forecast for the Global Fungal Infection Diagnosis Market ($B) by Application
Figure 6.4: Trends and Forecast for Hospitals in the Global Fungal Infection Diagnosis Market (2019-2035)
Figure 6.5: Trends and Forecast for Clinics in the Global Fungal Infection Diagnosis Market (2019-2035)
Figure 6.6: Trends and Forecast for Diagnostic Laboratories in the Global Fungal Infection Diagnosis Market (2019-2035)
Figure 6.7: Trends and Forecast for Research Institutes in the Global Fungal Infection Diagnosis Market (2019-2035)
Figure 6.8: Trends and Forecast for Others in the Global Fungal Infection Diagnosis Market (2019-2035)
Figure 7.1: Global Fungal Infection Diagnosis Market by End Use in 2019, 2026, and 2035
Figure 7.2: Trends of the Global Fungal Infection Diagnosis Market ($B) by End Use
Figure 7.3: Forecast for the Global Fungal Infection Diagnosis Market ($B) by End Use
Figure 7.4: Trends and Forecast for Hospitals in the Global Fungal Infection Diagnosis Market (2019-2035)
Figure 7.5: Trends and Forecast for Diagnostic Centers in the Global Fungal Infection Diagnosis Market (2019-2035)
Figure 7.6: Trends and Forecast for Research Laboratories in the Global Fungal Infection Diagnosis Market (2019-2035)
Figure 7.7: Trends and Forecast for Others in the Global Fungal Infection Diagnosis Market (2019-2035)
Figure 8.1: Trends of the Global Fungal Infection Diagnosis Market ($B) by Region (2019-2026)
Figure 8.2: Forecast for the Global Fungal Infection Diagnosis Market ($B) by Region (2027-2035)
Figure 9.1: Trends and Forecast for the North American Fungal Infection Diagnosis Market (2019-2035)
Figure 9.2: North American Fungal Infection Diagnosis Market by Product Type in 2019, 2026, and 2035
Figure 9.3: Trends of the North American Fungal Infection Diagnosis Market ($B) by Product Type (2019-2026)
Figure 9.4: Forecast for the North American Fungal Infection Diagnosis Market ($B) by Product Type (2027-2035)
Figure 9.5: North American Fungal Infection Diagnosis Market by Test Type in 2019, 2026, and 2035
Figure 9.6: Trends of the North American Fungal Infection Diagnosis Market ($B) by Test Type (2019-2026)
Figure 9.7: Forecast for the North American Fungal Infection Diagnosis Market ($B) by Test Type (2027-2035)
Figure 9.8: North American Fungal Infection Diagnosis Market by Application in 2019, 2026, and 2035
Figure 9.9: Trends of the North American Fungal Infection Diagnosis Market ($B) by Application (2019-2026)
Figure 9.10: Forecast for the North American Fungal Infection Diagnosis Market ($B) by Application (2027-2035)
Figure 9.11: North American Fungal Infection Diagnosis Market by End Use in 2019, 2026, and 2035
Figure 9.12: Trends of the North American Fungal Infection Diagnosis Market ($B) by End Use (2019-2026)
Figure 9.13: Forecast for the North American Fungal Infection Diagnosis Market ($B) by End Use (2027-2035)
Figure 9.14: Trends and Forecast for the United States Fungal Infection Diagnosis Market ($B) (2019-2035)
Figure 9.15: Trends and Forecast for the Mexican Fungal Infection Diagnosis Market ($B) (2019-2035)
Figure 9.16: Trends and Forecast for the Canadian Fungal Infection Diagnosis Market ($B) (2019-2035)
Figure 10.1: Trends and Forecast for the European Fungal Infection Diagnosis Market (2019-2035)
Figure 10.2: European Fungal Infection Diagnosis Market by Product Type in 2019, 2026, and 2035
Figure 10.3: Trends of the European Fungal Infection Diagnosis Market ($B) by Product Type (2019-2026)
Figure 10.4: Forecast for the European Fungal Infection Diagnosis Market ($B) by Product Type (2027-2035)
Figure 10.5: European Fungal Infection Diagnosis Market by Test Type in 2019, 2026, and 2035
Figure 10.6: Trends of the European Fungal Infection Diagnosis Market ($B) by Test Type (2019-2026)
Figure 10.7: Forecast for the European Fungal Infection Diagnosis Market ($B) by Test Type (2027-2035)
Figure 10.8: European Fungal Infection Diagnosis Market by Application in 2019, 2026, and 2035
Figure 10.9: Trends of the European Fungal Infection Diagnosis Market ($B) by Application (2019-2026)
Figure 10.10: Forecast for the European Fungal Infection Diagnosis Market ($B) by Application (2027-2035)
Figure 10.11: European Fungal Infection Diagnosis Market by End Use in 2019, 2026, and 2035
Figure 10.12: Trends of the European Fungal Infection Diagnosis Market ($B) by End Use (2019-2026)
Figure 10.13: Forecast for the European Fungal Infection Diagnosis Market ($B) by End Use (2027-2035)
Figure 10.14: Trends and Forecast for the German Fungal Infection Diagnosis Market ($B) (2019-2035)
Figure 10.15: Trends and Forecast for the French Fungal Infection Diagnosis Market ($B) (2019-2035)
Figure 10.16: Trends and Forecast for the Spanish Fungal Infection Diagnosis Market ($B) (2019-2035)
Figure 10.17: Trends and Forecast for the Italian Fungal Infection Diagnosis Market ($B) (2019-2035)
Figure 10.18: Trends and Forecast for the United Kingdom Fungal Infection Diagnosis Market ($B) (2019-2035)
Figure 11.1: Trends and Forecast for the APAC Fungal Infection Diagnosis Market (2019-2035)
Figure 11.2: APAC Fungal Infection Diagnosis Market by Product Type in 2019, 2026, and 2035
Figure 11.3: Trends of the APAC Fungal Infection Diagnosis Market ($B) by Product Type (2019-2026)
Figure 11.4: Forecast for the APAC Fungal Infection Diagnosis Market ($B) by Product Type (2027-2035)
Figure 11.5: APAC Fungal Infection Diagnosis Market by Test Type in 2019, 2026, and 2035
Figure 11.6: Trends of the APAC Fungal Infection Diagnosis Market ($B) by Test Type (2019-2026)
Figure 11.7: Forecast for the APAC Fungal Infection Diagnosis Market ($B) by Test Type (2027-2035)
Figure 11.8: APAC Fungal Infection Diagnosis Market by Application in 2019, 2026, and 2035
Figure 11.9: Trends of the APAC Fungal Infection Diagnosis Market ($B) by Application (2019-2026)
Figure 11.10: Forecast for the APAC Fungal Infection Diagnosis Market ($B) by Application (2027-2035)
Figure 11.11: APAC Fungal Infection Diagnosis Market by End Use in 2019, 2026, and 2035
Figure 11.12: Trends of the APAC Fungal Infection Diagnosis Market ($B) by End Use (2019-2026)
Figure 11.13: Forecast for the APAC Fungal Infection Diagnosis Market ($B) by End Use (2027-2035)
Figure 11.14: Trends and Forecast for the Japanese Fungal Infection Diagnosis Market ($B) (2019-2035)
Figure 11.15: Trends and Forecast for the Indian Fungal Infection Diagnosis Market ($B) (2019-2035)
Figure 11.16: Trends and Forecast for the Chinese Fungal Infection Diagnosis Market ($B) (2019-2035)
Figure 11.17: Trends and Forecast for the South Korean Fungal Infection Diagnosis Market ($B) (2019-2035)
Figure 11.18: Trends and Forecast for the Indonesian Fungal Infection Diagnosis Market ($B) (2019-2035)
Figure 12.1: Trends and Forecast for the ROW Fungal Infection Diagnosis Market (2019-2035)
Figure 12.2: ROW Fungal Infection Diagnosis Market by Product Type in 2019, 2026, and 2035
Figure 12.3: Trends of the ROW Fungal Infection Diagnosis Market ($B) by Product Type (2019-2026)
Figure 12.4: Forecast for the ROW Fungal Infection Diagnosis Market ($B) by Product Type (2027-2035)
Figure 12.5: ROW Fungal Infection Diagnosis Market by Test Type in 2019, 2026, and 2035
Figure 12.6: Trends of the ROW Fungal Infection Diagnosis Market ($B) by Test Type (2019-2026)
Figure 12.7: Forecast for the ROW Fungal Infection Diagnosis Market ($B) by Test Type (2027-2035)
Figure 12.8: ROW Fungal Infection Diagnosis Market by Application in 2019, 2026, and 2035
Figure 12.9: Trends of the ROW Fungal Infection Diagnosis Market ($B) by Application (2019-2026)
Figure 12.10: Forecast for the ROW Fungal Infection Diagnosis Market ($B) by Application (2027-2035)
Figure 12.11: ROW Fungal Infection Diagnosis Market by End Use in 2019, 2026, and 2035
Figure 12.12: Trends of the ROW Fungal Infection Diagnosis Market ($B) by End Use (2019-2026)
Figure 12.13: Forecast for the ROW Fungal Infection Diagnosis Market ($B) by End Use (2027-2035)
Figure 12.14: Trends and Forecast for the Middle Eastern Fungal Infection Diagnosis Market ($B) (2019-2035)
Figure 12.15: Trends and Forecast for the South American Fungal Infection Diagnosis Market ($B) (2019-2035)
Figure 12.16: Trends and Forecast for the African Fungal Infection Diagnosis Market ($B) (2019-2035)
Figure 13.1: Porter's Five Forces Analysis of the Global Fungal Infection Diagnosis Market
Figure 13.2: Market Share (%) of Top Players in the Global Fungal Infection Diagnosis Market (2026)
Figure 14.1: Growth Opportunities for the Global Fungal Infection Diagnosis Market by Product Type
Figure 14.2: Growth Opportunities for the Global Fungal Infection Diagnosis Market by Test Type
Figure 14.3: Growth Opportunities for the Global Fungal Infection Diagnosis Market by Application
Figure 14.4: Growth Opportunities for the Global Fungal Infection Diagnosis Market by End Use
Figure 14.5: Growth Opportunities for the Global Fungal Infection Diagnosis Market by Region
Figure 14.6: Emerging Trends in the Global Fungal Infection Diagnosis Market

List of Tables

Table 1.1: Growth Rate (%, 2025-2026) and CAGR (%, 2027-2035) of the Fungal Infection Diagnosis Market by Product Type, Test Type, Application, and End Use
Table 1.2: Attractiveness Analysis for the Fungal Infection Diagnosis Market by Region
Table 1.3: Global Fungal Infection Diagnosis Market Parameters and Attributes
Table 3.1: Trends of the Global Fungal Infection Diagnosis Market (2019-2026)
Table 3.2: Forecast for the Global Fungal Infection Diagnosis Market (2027-2035)
Table 4.1: Attractiveness Analysis for the Global Fungal Infection Diagnosis Market by Product Type
Table 4.2: Market Size and CAGR of Various Product Type in the Global Fungal Infection Diagnosis Market (2019-2026)
Table 4.3: Market Size and CAGR of Various Product Type in the Global Fungal Infection Diagnosis Market (2027-2035)
Table 4.4: Trends of Instruments in the Global Fungal Infection Diagnosis Market (2019-2026)
Table 4.5: Forecast for Instruments in the Global Fungal Infection Diagnosis Market (2027-2035)
Table 4.6: Trends of Reagents & Kits in the Global Fungal Infection Diagnosis Market (2019-2026)
Table 4.7: Forecast for Reagents & Kits in the Global Fungal Infection Diagnosis Market (2027-2035)
Table 4.8: Trends of Software in the Global Fungal Infection Diagnosis Market (2019-2026)
Table 4.9: Forecast for Software in the Global Fungal Infection Diagnosis Market (2027-2035)
Table 5.1: Attractiveness Analysis for the Global Fungal Infection Diagnosis Market by Test Type
Table 5.2: Market Size and CAGR of Various Test Type in the Global Fungal Infection Diagnosis Market (2019-2026)
Table 5.3: Market Size and CAGR of Various Test Type in the Global Fungal Infection Diagnosis Market (2027-2035)
Table 5.4: Trends of Molecular Tests in the Global Fungal Infection Diagnosis Market (2019-2026)
Table 5.5: Forecast for Molecular Tests in the Global Fungal Infection Diagnosis Market (2027-2035)
Table 5.6: Trends of Immunoassays in the Global Fungal Infection Diagnosis Market (2019-2026)
Table 5.7: Forecast for Immunoassays in the Global Fungal Infection Diagnosis Market (2027-2035)
Table 5.8: Trends of Microscopy in the Global Fungal Infection Diagnosis Market (2019-2026)
Table 5.9: Forecast for Microscopy in the Global Fungal Infection Diagnosis Market (2027-2035)
Table 5.10: Trends of Culture-Based Tests in the Global Fungal Infection Diagnosis Market (2019-2026)
Table 5.11: Forecast for Culture-Based Tests in the Global Fungal Infection Diagnosis Market (2027-2035)
Table 5.12: Trends of Others in the Global Fungal Infection Diagnosis Market (2019-2026)
Table 5.13: Forecast for Others in the Global Fungal Infection Diagnosis Market (2027-2035)
Table 6.1: Attractiveness Analysis for the Global Fungal Infection Diagnosis Market by Application
Table 6.2: Market Size and CAGR of Various Application in the Global Fungal Infection Diagnosis Market (2019-2026)
Table 6.3: Market Size and CAGR of Various Application in the Global Fungal Infection Diagnosis Market (2027-2035)
Table 6.4: Trends of Hospitals in the Global Fungal Infection Diagnosis Market (2019-2026)
Table 6.5: Forecast for Hospitals in the Global Fungal Infection Diagnosis Market (2027-2035)
Table 6.6: Trends of Clinics in the Global Fungal Infection Diagnosis Market (2019-2026)
Table 6.7: Forecast for Clinics in the Global Fungal Infection Diagnosis Market (2027-2035)
Table 6.8: Trends of Diagnostic Laboratories in the Global Fungal Infection Diagnosis Market (2019-2026)
Table 6.9: Forecast for Diagnostic Laboratories in the Global Fungal Infection Diagnosis Market (2027-2035)
Table 6.10: Trends of Research Institutes in the Global Fungal Infection Diagnosis Market (2019-2026)
Table 6.11: Forecast for Research Institutes in the Global Fungal Infection Diagnosis Market (2027-2035)
Table 6.12: Trends of Others in the Global Fungal Infection Diagnosis Market (2019-2026)
Table 6.13: Forecast for Others in the Global Fungal Infection Diagnosis Market (2027-2035)
Table 7.1: Attractiveness Analysis for the Global Fungal Infection Diagnosis Market by End Use
Table 7.2: Market Size and CAGR of Various End Use in the Global Fungal Infection Diagnosis Market (2019-2026)
Table 7.3: Market Size and CAGR of Various End Use in the Global Fungal Infection Diagnosis Market (2027-2035)
Table 7.4: Trends of Hospitals in the Global Fungal Infection Diagnosis Market (2019-2026)
Table 7.5: Forecast for Hospitals in the Global Fungal Infection Diagnosis Market (2027-2035)
Table 7.6: Trends of Diagnostic Centers in the Global Fungal Infection Diagnosis Market (2019-2026)
Table 7.7: Forecast for Diagnostic Centers in the Global Fungal Infection Diagnosis Market (2027-2035)
Table 7.8: Trends of Research Laboratories in the Global Fungal Infection Diagnosis Market (2019-2026)
Table 7.9: Forecast for Research Laboratories in the Global Fungal Infection Diagnosis Market (2027-2035)
Table 7.10: Trends of Others in the Global Fungal Infection Diagnosis Market (2019-2026)
Table 7.11: Forecast for Others in the Global Fungal Infection Diagnosis Market (2027-2035)
Table 8.1: Market Size and CAGR of Various Regions in the Global Fungal Infection Diagnosis Market (2019-2026)
Table 8.2: Market Size and CAGR of Various Regions in the Global Fungal Infection Diagnosis Market (2027-2035)
Table 9.1: Trends of the North American Fungal Infection Diagnosis Market (2019-2026)
Table 9.2: Forecast for the North American Fungal Infection Diagnosis Market (2027-2035)
Table 9.3: Market Size and CAGR of Various Product Type in the North American Fungal Infection Diagnosis Market (2019-2026)
Table 9.4: Market Size and CAGR of Various Product Type in the North American Fungal Infection Diagnosis Market (2027-2035)
Table 9.5: Market Size and CAGR of Various Test Type in the North American Fungal Infection Diagnosis Market (2019-2026)
Table 9.6: Market Size and CAGR of Various Test Type in the North American Fungal Infection Diagnosis Market (2027-2035)
Table 9.7: Market Size and CAGR of Various Application in the North American Fungal Infection Diagnosis Market (2019-2026)
Table 9.8: Market Size and CAGR of Various Application in the North American Fungal Infection Diagnosis Market (2027-2035)
Table 9.9: Market Size and CAGR of Various End Use in the North American Fungal Infection Diagnosis Market (2019-2026)
Table 9.10: Market Size and CAGR of Various End Use in the North American Fungal Infection Diagnosis Market (2027-2035)
Table 9.11: Trends and Forecast for the United States Fungal Infection Diagnosis Market (2019-2035)
Table 9.12: Trends and Forecast for the Mexican Fungal Infection Diagnosis Market (2019-2035)
Table 9.13: Trends and Forecast for the Canadian Fungal Infection Diagnosis Market (2019-2035)
Table 10.1: Trends of the European Fungal Infection Diagnosis Market (2019-2026)
Table 10.2: Forecast for the European Fungal Infection Diagnosis Market (2027-2035)
Table 10.3: Market Size and CAGR of Various Product Type in the European Fungal Infection Diagnosis Market (2019-2026)
Table 10.4: Market Size and CAGR of Various Product Type in the European Fungal Infection Diagnosis Market (2027-2035)
Table 10.5: Market Size and CAGR of Various Test Type in the European Fungal Infection Diagnosis Market (2019-2026)
Table 10.6: Market Size and CAGR of Various Test Type in the European Fungal Infection Diagnosis Market (2027-2035)
Table 10.7: Market Size and CAGR of Various Application in the European Fungal Infection Diagnosis Market (2019-2026)
Table 10.8: Market Size and CAGR of Various Application in the European Fungal Infection Diagnosis Market (2027-2035)
Table 10.9: Market Size and CAGR of Various End Use in the European Fungal Infection Diagnosis Market (2019-2026)
Table 10.10: Market Size and CAGR of Various End Use in the European Fungal Infection Diagnosis Market (2027-2035,)
Table 10.11: Trends and Forecast for the German Fungal Infection Diagnosis Market (2019-2035)
Table 10.12: Trends and Forecast for the French Fungal Infection Diagnosis Market (2019-2035)
Table 10.13: Trends and Forecast for the Spanish Fungal Infection Diagnosis Market (2019-2035)
Table 10.14: Trends and Forecast for the Italian Fungal Infection Diagnosis Market (2019-2035)
Table 10.15: Trends and Forecast for the United Kingdom Fungal Infection Diagnosis Market (2019-2035)
Table 11.1: Trends of the APAC Fungal Infection Diagnosis Market (2019-2026)
Table 11.2: Forecast for the APAC Fungal Infection Diagnosis Market (2027-2035)
Table 11.3: Market Size and CAGR of Various Product Type in the APAC Fungal Infection Diagnosis Market (2019-2026)
Table 11.4: Market Size and CAGR of Various Product Type in the APAC Fungal Infection Diagnosis Market (2027-2035)
Table 11.5: Market Size and CAGR of Various Test Type in the APAC Fungal Infection Diagnosis Market (2019-2026)
Table 11.6: Market Size and CAGR of Various Test Type in the APAC Fungal Infection Diagnosis Market (2027-2035)
Table 11.7: Market Size and CAGR of Various Application in the APAC Fungal Infection Diagnosis Market (2019-2026)
Table 11.8: Market Size and CAGR of Various Application in the APAC Fungal Infection Diagnosis Market (2027-2035)
Table 11.9: Market Size and CAGR of Various End Use in the APAC Fungal Infection Diagnosis Market (2019-2026)
Table 11.10: Market Size and CAGR of Various End Use in the APAC Fungal Infection Diagnosis Market (2027-2035)
Table 11.11: Trends and Forecast for the Japanese Fungal Infection Diagnosis Market (2019-2035)
Table 11.12: Trends and Forecast for the Indian Fungal Infection Diagnosis Market (2019-2035)
Table 11.13: Trends and Forecast for the Chinese Fungal Infection Diagnosis Market (2019-2035)
Table 11.14: Trends and Forecast for the South Korean Fungal Infection Diagnosis Market (2019-2035)
Table 11.15: Trends and Forecast for the Indonesian Fungal Infection Diagnosis Market (2019-2035)
Table 12.1: Trends of the ROW Fungal Infection Diagnosis Market (2019-2026)
Table 12.2: Forecast for the ROW Fungal Infection Diagnosis Market (2027-2035)
Table 12.3: Market Size and CAGR of Various Product Type in the ROW Fungal Infection Diagnosis Market (2019-2026)
Table 12.4: Market Size and CAGR of Various Product Type in the ROW Fungal Infection Diagnosis Market (2027-2035)
Table 12.5: Market Size and CAGR of Various Test Type in the ROW Fungal Infection Diagnosis Market (2019-2026)
Table 12.6: Market Size and CAGR of Various Test Type in the ROW Fungal Infection Diagnosis Market (2027-2035)
Table 12.7: Market Size and CAGR of Various Application in the ROW Fungal Infection Diagnosis Market (2019-2026)
Table 12.8: Market Size and CAGR of Various Application in the ROW Fungal Infection Diagnosis Market (2027-2035)
Table 12.9: Market Size and CAGR of Various End Use in the ROW Fungal Infection Diagnosis Market (2019-2026)
Table 12.10: Market Size and CAGR of Various End Use in the ROW Fungal Infection Diagnosis Market (2027-2035)
Table 12.11: Trends and Forecast for the Middle Eastern Fungal Infection Diagnosis Market (2019-2035)
Table 12.12: Trends and Forecast for the South American Fungal Infection Diagnosis Market (2019-2035)
Table 12.13: Trends and Forecast for the African Fungal Infection Diagnosis Market (2019-2035)
Table 13.1: Product Mapping of Fungal Infection Diagnosis Suppliers Based on Segments
Table 13.2: Operational Integration of Fungal Infection Diagnosis Manufacturers
Table 13.3: Rankings of Suppliers Based on Fungal Infection Diagnosis Revenue
Table 14.1: New Product Launches by Major Fungal Infection Diagnosis Producers (2019-2026)
Table 14.2: Certification Acquired by Major Competitor in the Global Fungal Infection Diagnosis Market